Days after drumming up $6 million in a debt sale, CardioFocus Inc. got the OK to begin marketing its Endoscopic Ablation System atrial fibrillation catheter in the European Union.
The Marlborough cardiac device maker said the system consists of a micro-endoscope physicians use to see within the heart and direct energy through a catheter to the fibrillating tissue in the heart’s atrial chamber.